These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 23621549)
1. Neutrophilic dermatosis of the dorsal hands during thalidomide treatment. Mathieu S; Soubrier M; Tournadre A; Dubost JJ Int J Dermatol; 2014 Sep; 53(9):1133-5. PubMed ID: 23621549 [No Abstract] [Full Text] [Related]
2. Neutrophilic dermatosis of the dorsal hands: a localized variant of Sweet's syndrome or a distinct entity? Nofal A; Assaf M; Elakad R; Fawzy M; Nofal E Int J Dermatol; 2015 Feb; 54(2):e66-7. PubMed ID: 25515156 [No Abstract] [Full Text] [Related]
3. Neutrophilic dermatosis complicating lenalidomide therapy. Thieu KP; Rosenbach M; Xu X; Kist JM J Am Acad Dermatol; 2009 Oct; 61(4):709-10. PubMed ID: 19577327 [TBL] [Abstract][Full Text] [Related]
7. Neutrophilic dermatosis of the hands after influenza vaccination. Wolf R; Barzilai A; Davidovici B Int J Dermatol; 2009 Jan; 48(1):66-8. PubMed ID: 19126054 [TBL] [Abstract][Full Text] [Related]
8. Neutrophilic dermatosis (Sweet syndrome) of the hands associated with lenalidomide. Hoverson AR; Davis MD; Weenig RH; Wolanskyj AP Arch Dermatol; 2006 Aug; 142(8):1070-1. PubMed ID: 16924066 [No Abstract] [Full Text] [Related]
10. Leukocytoclastic vasculitis due to thalidomide in multiple myeloma. Yildirim ND; Ayer M; Küçükkaya RD; Alpay N; Mete O; Yenerel MN; Yavuz AS; Nalçaci M Jpn J Clin Oncol; 2007 Sep; 37(9):704-7. PubMed ID: 17709605 [TBL] [Abstract][Full Text] [Related]
11. Tumor lysis syndrome at the beginning of thalidomide therapy for multiple myeloma. Cany L; Fitoussi O; Boiron JM; Marit G J Clin Oncol; 2002 Apr; 20(8):2212. PubMed ID: 11956286 [No Abstract] [Full Text] [Related]
12. Localized palmar vancomycin-induced linear IgA bullous dermatosis occurring at supratherapeutic levels. Walsh SN; Kerchner K; Sangüeza OP Arch Dermatol; 2009 May; 145(5):603-4. PubMed ID: 19451516 [No Abstract] [Full Text] [Related]
13. Toxic epidermal necrolysis following thalidomide and dexamethasone treatment for multiple myeloma: a case report. Eo WK; Kim SH; Cheon SH; Lee SH; Jeong JS; Kim YS; Chang HK; Suh KS; Kim HY Ann Hematol; 2010 Apr; 89(4):421-2. PubMed ID: 19693501 [No Abstract] [Full Text] [Related]
14. Anti-neutrophil cytoplasmic antibody-positive neutrophilic dermatosis of the dorsal hands. Malik M; Perkins W; Leach I Clin Exp Dermatol; 2012 Dec; 37(8):869-70. PubMed ID: 22548627 [TBL] [Abstract][Full Text] [Related]
16. Recombinant human erythropoietin and the risk of thrombosis in patients receiving thalidomide for multiple myeloma. Galli M; Elice F; Crippa C; Comotti B; Rodeghiero F; Barbui T Haematologica; 2004 Sep; 89(9):1141-2. PubMed ID: 15377478 [TBL] [Abstract][Full Text] [Related]
17. Neutrophilic dermatoses: a review of current treatment options. Cohen PR Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442 [TBL] [Abstract][Full Text] [Related]
19. Tumor lysis syndrome in a multiple myeloma treated with thalidomide. Fuente N; Mañe JM; Barcelo R; Muñoz A; Perez-Hoyos T; Lopez-Vivanco G Ann Oncol; 2004 Mar; 15(3):537. PubMed ID: 14998862 [No Abstract] [Full Text] [Related]
20. Erythematous bullous lesions on the dorsa of the hands due to contact exposure to ibutilide fumarate for injection. Dodds ES; Oberg KC Pharmacotherapy; 1998; 18(4):880-2. PubMed ID: 9692669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]